El tamaño del mercado de envases parenterales farmacéuticos está valorado en USD 13,20 mil millones en 2023 y se proyecta que alcance los USD 18,81 mil millones para 2032, creciendo a una CAGR del 4,45% durante el período de pronóstico de 2024 a 2032.
El envasado parenteral farmacéutico abarca técnicas especializadas diseñadas para almacenar y administrar productos farmacéuticos estériles a través de infusiones, inyecciones intramusculares o epidérmicas, sin pasar por el tracto digestivo. Estas soluciones de envasado garantizan que el producto permanezca intacto, estéril y seguro durante todo su ciclo de vida, desde el almacenamiento y el transporte hasta la administración. El mercado está experimentando un crecimiento impulsado por la creciente prevalencia de enfermedades crónicas, el aumento del uso de medicamentos inyectables, un mayor enfoque en la seguridad del paciente y la creciente adopción de productos biológicos, jeringas precargadas y dispositivos de inyección. Se prevé que estos factores aumenten la demanda de soluciones de envasado parenteral farmacéutico y respalden la expansión del mercado.
Sin embargo, se espera que el crecimiento del mercado enfrente desafíos debido a las estrictas regulaciones y estándares gubernamentales, así como a los altos costos de las materias primas utilizadas en el envasado de productos parenterales farmacéuticos.
Atributo del informe | Presupuesto |
Valor del tamaño del mercado en 2023 | USD 13,20 mil millones |
Previsión de ingresos en 2032 | USD 18.81 mil millones |
Tasa de crecimiento CAGR | CAGR del 4,45% entre 2024 y 2032 |
Unidades cuantitativas | Representación de ingresos en millones de dólares y CAGR de 2024 a 2032 |
Año histórico | 2019 a 2023 |
Año de pronóstico | 2024-2032 |
Cobertura del informe | La previsión de ingresos, la posición de la empresa, la estructura competitiva del mercado, las perspectivas de crecimiento y las tendencias. |
Por tipo |
|
Por aplicación |
|
Por región |
|
Alcance de personalización | Informe de personalización gratuito con la adquisición del informe y modificaciones del alcance regional y de segmentos. Entorno competitivo geográfico particular. |
Panorama competitivo | Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., Ardena Holding NV, Baxter International Inc., Becton, Dickinson and Company, Berkshire Sterile Manufacturing, Berry Global Inc., Catalent Inc., Gerresheimer AG, Nipro Corporation, PCI Pharma Services, Schott AG, SGD Pharma, SiO2 Materials Science, Stevanato Group S.p.A, Terumo Corporation, UDG Healthcare Plc., West Pharmaceutical Services, Inc., Ypsomed Holding AG. |
Pharma Parenteral Packaging Market size is valued at USD 13.20 Billion in 2023 and is projected to reach USD 18.81 Billion by 2032.
The market is expected to grow at a CAGR of 4.45% from 2024 to 2032.
Major key players include Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., and others.
January 2024: SCHOTT Pharma expanded its global manufacturing network by investing a double-digit million euros in a new production site for pharma drug containment solutions and delivery systems in Jagodina, central Serbia.
October 2023: Gerresheimer launched COP (Cyclic Olefin Polymer) to fill and store sensitive biopharmaceutical mRNA active ingredients.
2023: B.D. introduced the all-in-one prefilled flush syringe with an integrated disinfection unit.
The prefilled syringes segment is anticipated to be a major contributor to the pharma parenteral packaging market. The segment's growth is driven by the ease of use of prefilled syringes, their preference for small molecules over other dosage forms, lower dosage errors, and the rising demand for prefilled insulin syringes due to the increasing incidence of diabetes.
Glass Material SegmentThe glass segment is expected to witness rapid growth, primarily due to glass's impermeable and non-porous nature, which helps retain product composition. Glass also protects items from ultraviolet radiation, ensuring longer freshness, particularly in countries like the US, Germany, the UK, China, and India.
North America holds a significant revenue share in the pharma parenteral packaging market. This is attributed to the presence of prominent parenteral packaging companies, the increasing demand for injectable medication packaging, and the overall growth of the pharmaceutical industry in the region.
Asia-PacificThe Asia-Pacific region is projected to grow at the highest rate during the study period. The growth is driven by the increasing incidence of chronic and infectious diseases, the rising need for pharmaceutical vial packaging, and the expansion of vaccination programs.
The Pharma Parenteral Packaging Market is poised for significant growth driven by the increasing demand for safe and sterile pharmaceutical packaging solutions. Despite challenges such as stringent regulations and high raw material costs, advancements in packaging technologies and the growing adoption of biologics and injectable drugs are expected to support market expansion. The competitive landscape features key players continuously innovating to meet evolving market needs, ensuring the safe and effective delivery of pharmaceutical products.
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.